Oncternal Therapeutics (ONCT) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free ONCT Stock Alerts $8.18 -0.46 (-5.32%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 9) -$2.83 Beat By $0.05 Consensus EPS (May. 9) -$2.88 Read Call TranscriptListen to Call Get Oncternal Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ONCT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueONCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONCT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Oncternal Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($3.30)($2.59)($2.95)Q2 20242($3.42)($2.52)($2.97)Q3 20242($3.63)($2.26)($2.95)Q4 20242($3.68)($2.19)($2.94)FY 20248($14.03)($9.56)($11.80)ONCT Earnings Date and InformationOncternal Therapeutics last issued its quarterly earnings data on May 9th, 2024. The reported ($2.83) EPS for the quarter, topping the consensus estimate of ($2.88) by $0.05. The business earned $0.57 million during the quarter, compared to the consensus estimate of $0.18 million. Oncternal Therapeutics has generated ($12.34) earnings per share over the last year (($12.34) diluted earnings per share). Earnings for Oncternal Therapeutics are expected to grow in the coming year, from ($10.67) to ($9.63) per share. Oncternal Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Oncternal Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 5/9/2024Q1 2024($2.88)($2.83)+$0.05($2.83)$0.18 million$0.57 million 3/7/2024Q4 2023($3.09)($3.11)($0.02)($3.11)$0.17 million$0.30 million 11/9/2023Q3 2023($3.00)($3.40)($0.40)($0.17)$0.17 million$0.18 million 8/10/2023Q2 2023($3.40)($3.00)+$0.40($0.15)$0.21 million$0.11 million5/4/2023Q1 2023($4.20)($4.00)+$0.20($0.20)$0.20 million$0.20 million3/9/2023Q4 2022($4.40)($4.00)+$0.40($0.20)$0.37 million$0.17 million Get the Latest News and Ratings for ONCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncternal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($4.80)($4.20)+$0.60($0.21)$0.43 million$0.38 million8/9/2022Q2 2022($4.60)($4.60)-($0.23)$0.57 million$0.19 million5/5/2022Q1 2022($3.80)($4.00)($0.20)($0.20)$0.70 million$0.75 million 3/10/2022Q4 2021($5.00)($3.20)+$1.80($0.16)$2.03 million$0.56 million 11/4/2021Q3 2021($3.20)($3.80)($0.60)($0.19)$1.30 million$2.13 million 8/5/2021Q2 2021($2.80)($3.20)($0.40)($0.16)$1.09 million$0.88 million Oncternal Therapeutics Earnings - Frequently Asked Questions When is Oncternal Therapeutics's earnings date? Oncternal Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on ONCT's earnings history. Did Oncternal Therapeutics beat their earnings estimates last quarter? In the previous quarter, Oncternal Therapeutics (NASDAQ:ONCT) reported ($2.83) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.88) by $0.05. Learn more on analysts' earnings estimate vs. ONCT's actual earnings. How can I listen to Oncternal Therapeutics's earnings conference call? The conference call for Oncternal Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Oncternal Therapeutics's conference call transcript? The conference call transcript for Oncternal Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Oncternal Therapeutics generate each year? Oncternal Therapeutics (NASDAQ:ONCT) has a recorded annual revenue of $790,000.00. How much profit does Oncternal Therapeutics generate each year? Oncternal Therapeutics (NASDAQ:ONCT) has a recorded net income of -$39.48 million. ONCT has generated -$12.34 earnings per share over the last four quarters. What is Oncternal Therapeutics's EPS forecast for next year? Oncternal Therapeutics's earnings are expected to grow from ($10.67) per share to ($9.63) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Iterum Therapeutics Earnings Date Forte Biosciences Earnings Date Lumos Pharma Earnings Date Biora Therapeutics Earnings Date Lipocine Earnings Date Unity Biotechnology Earnings Date Lisata Therapeutics Earnings Date Acasti Pharma Earnings Date TherapeuticsMD Earnings Date Bullfrog AI Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ONCT) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchYou need to know these two things about AI stocks ASAP…InvestorPlace[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
